Myriad, Rival Strike Deal In Cancer-Test Patent Dispute
Myriad Genetics Inc. has settled its suit against Gene by Gene Ltd. over alleged infringement of its cancer-testing patents, including several that were upheld in a landmark U.S. Supreme Court decision...To view the full article, register now.
Already a subscriber? Click here to view full article